EP0831920A4 - Novel cathepsin and methods and compositions for inhibition thereof - Google Patents
Novel cathepsin and methods and compositions for inhibition thereofInfo
- Publication number
- EP0831920A4 EP0831920A4 EP96913917A EP96913917A EP0831920A4 EP 0831920 A4 EP0831920 A4 EP 0831920A4 EP 96913917 A EP96913917 A EP 96913917A EP 96913917 A EP96913917 A EP 96913917A EP 0831920 A4 EP0831920 A4 EP 0831920A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- inhibition
- compositions
- methods
- novel cathepsin
- cathepsin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US467607 | 1995-06-06 | ||
US08/469,362 US5849711A (en) | 1995-06-06 | 1995-06-06 | Cathepsin and methods and compositions for inhibition thereof |
US469362 | 1995-06-06 | ||
US08/467,607 US5783434A (en) | 1995-06-06 | 1995-06-06 | Cathepsin and methods and compositions for inhibition thereof |
PCT/US1996/006211 WO1996039194A1 (en) | 1995-06-06 | 1996-04-26 | Novel cathepsin and methods and compositions for inhibition thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0831920A1 EP0831920A1 (en) | 1998-04-01 |
EP0831920A4 true EP0831920A4 (en) | 2003-03-19 |
Family
ID=27042111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96913917A Withdrawn EP0831920A4 (en) | 1995-06-06 | 1996-04-26 | Novel cathepsin and methods and compositions for inhibition thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0831920A4 (en) |
JP (1) | JPH11506923A (en) |
CA (1) | CA2221684A1 (en) |
WO (1) | WO1996039194A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU714324B2 (en) * | 1995-11-28 | 2000-01-06 | Cephalon, Inc. | D-amino acid derived inhibitors of cysteine and serine proteases |
US6191166B1 (en) | 1997-11-21 | 2001-02-20 | Elan Pharmaceuticals, Inc. | Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
US6117901A (en) | 1996-11-22 | 2000-09-12 | Athena Neurosciences, Inc. | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for use |
US6211235B1 (en) | 1996-11-22 | 2001-04-03 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
US6642261B2 (en) | 1997-11-21 | 2003-11-04 | Athena Neurosciences, Inc. | N-(aryl/heteroarylacety) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US5965614A (en) * | 1996-11-22 | 1999-10-12 | Athena Neurosciences, Inc. | N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6153652A (en) * | 1996-11-22 | 2000-11-28 | Elan Pharmaceuticals, Inc. | N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
AR016751A1 (en) * | 1996-11-22 | 2001-08-01 | Athena Neurosciences Inc | METHOD FOR INHIBITING THE RELEASE OF THE BETA-AMYLOID PEPTIDE IN A CELL, PHARMACEUTICAL COMPOSITION AND USEFUL COMPOUNDS IN THIS METHOD |
US6207710B1 (en) | 1996-11-22 | 2001-03-27 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting β-amyloid peptide release and/or its synthesis |
KR20000069075A (en) * | 1996-11-22 | 2000-11-25 | 진 엠. 듀발 | N-(Aryl/Heteroaryl/Alkylacethyl)Amino Acid Amides, Pharmaceutical Compositions Comprising Same, and Methods for Inhibiting Beta-Amyloid Peptide Release and/or its Synthesis by Use of Such Compounds |
DE19648793A1 (en) | 1996-11-26 | 1998-05-28 | Basf Ag | New benzamides and their application |
HRP980093A2 (en) * | 1997-02-28 | 1998-12-31 | Lilly Co Eli | Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting "beta"-amyloid peptide release and/or its synthesis by use of such compounds |
WO1999031256A2 (en) * | 1997-12-18 | 1999-06-24 | Immunex Corporation | Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis |
US6506782B1 (en) | 1998-02-27 | 2003-01-14 | Athena Neurosciences, Inc. | Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
SK15062000A3 (en) * | 1998-04-20 | 2001-05-10 | Basf Aktiengesellschaft | Novel heterocyclically substituted amides with cysteine protease-inhibiting effect |
DE19818614A1 (en) * | 1998-04-20 | 1999-10-21 | Basf Ag | New benzamide derivatives useful as cysteine protease inhibitors for treating neurodegenerative diseases, neuronal damage, stroke, cranial trauma, Alzheimer's disease, etc. |
WO2000024392A1 (en) * | 1998-10-26 | 2000-05-04 | Sumitomo Pharmaceuticals Company, Limited | β-AMYLOID FORMATION INHIBITORS |
ES2296834T3 (en) * | 2002-02-14 | 2008-05-01 | Biofrontera Pharmaceuticals Ag | INHIBITORS OF CATEPSIN AND FOR THE DEVELOPMENT OF A MEDICINAL PRODUCT FOR THE TREATMENT OF PAIN. |
CA2479724A1 (en) | 2002-03-19 | 2003-10-02 | Tularik Inc. | Gene amplification in cancer |
EP1347059A1 (en) * | 2002-03-20 | 2003-09-24 | Biofrontera Pharmaceuticals AG | Cathepsin Y for the development of a medicament for the treatment of stroke |
US8263044B2 (en) * | 2005-11-10 | 2012-09-11 | Orchid Research Laboratories Limited | Stilbene like compounds as novel HDAC inhibitors |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995009838A1 (en) * | 1993-10-01 | 1995-04-13 | Merrell Pharmaceuticals Inc. | INHIBITORS OF β-AMYLOID PROTEIN PRODUCTION |
EP0652009A1 (en) * | 1993-08-09 | 1995-05-10 | Eli Lilly And Company | Identification and use of protease inhibitors |
WO1995013084A1 (en) * | 1992-05-11 | 1995-05-18 | Miles Inc. | Cathepsin d is an amyloidogenic protease in alzheimer's disease |
EP0659418A1 (en) * | 1993-12-21 | 1995-06-28 | Eli Lilly And Company | 2-Phenyl-3-azoylbenzothiophene for treating Alzheimer's disease |
EP0670309A1 (en) * | 1992-11-20 | 1995-09-06 | Japan Tobacco Inc. | Compound with prolyl endopeptidase inhibitor activity and pharmaceutical use thereof |
WO1996020725A2 (en) * | 1995-01-06 | 1996-07-11 | Sibia Neurosciences, Inc. | Peptide, peptide analog and amino acid analog protease inhibitors |
WO1996022966A1 (en) * | 1995-01-23 | 1996-08-01 | Biogen, Inc. | Cell adhesion inhibitors |
EP0732399A2 (en) * | 1990-03-05 | 1996-09-18 | Cephalon, Inc. | Chymotrypsin-like proteases and their inhibitors |
WO1997030072A1 (en) * | 1996-02-20 | 1997-08-21 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5221607A (en) * | 1989-09-18 | 1993-06-22 | Scios Nova Inc. | Assays and reagents for amyloid deposition |
US5242932A (en) * | 1991-12-17 | 1993-09-07 | The Rockefeller University | Treatment of amyloidosis associated with alzheimer disease |
US5164295A (en) * | 1991-03-06 | 1992-11-17 | The Upjohn Company | Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds |
US5538845A (en) * | 1992-02-05 | 1996-07-23 | Athena Neurosciences, Inc. | Beta-amyloid peptide production inhibitors and methods for their identification |
US5441870A (en) * | 1992-04-15 | 1995-08-15 | Athena Neurosciences, Inc. | Methods for monitoring cellular processing of β-amyloid precursor protein |
IL106877A (en) * | 1992-09-10 | 1998-03-10 | Lilly Co Eli | Rhodanine derivatives for use as medicaments for the treatment of alzheimer's disease |
US5478857A (en) * | 1993-12-23 | 1995-12-26 | Eli Lilly And Company | Use of PLA2 inhibitors as treatment for alzheimer's disease |
WO1995031192A1 (en) * | 1994-05-16 | 1995-11-23 | Thomas Jefferson University | Method and use of agents to inhibit protein polymerization and methods of identifying these agents |
CA2152765A1 (en) * | 1994-06-30 | 1995-12-31 | Jeroen Elisabeth-Joseph Knops | Methods for treating a physiological disorder associated with beta amyloid peptide |
US5523295A (en) * | 1994-07-06 | 1996-06-04 | Brandeis University | Method for treating and preventing alzheimer's disease |
-
1996
- 1996-04-26 WO PCT/US1996/006211 patent/WO1996039194A1/en not_active Application Discontinuation
- 1996-04-26 EP EP96913917A patent/EP0831920A4/en not_active Withdrawn
- 1996-04-26 CA CA002221684A patent/CA2221684A1/en not_active Abandoned
- 1996-04-26 JP JP9500507A patent/JPH11506923A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0732399A2 (en) * | 1990-03-05 | 1996-09-18 | Cephalon, Inc. | Chymotrypsin-like proteases and their inhibitors |
WO1995013084A1 (en) * | 1992-05-11 | 1995-05-18 | Miles Inc. | Cathepsin d is an amyloidogenic protease in alzheimer's disease |
EP0670309A1 (en) * | 1992-11-20 | 1995-09-06 | Japan Tobacco Inc. | Compound with prolyl endopeptidase inhibitor activity and pharmaceutical use thereof |
EP0652009A1 (en) * | 1993-08-09 | 1995-05-10 | Eli Lilly And Company | Identification and use of protease inhibitors |
WO1995009838A1 (en) * | 1993-10-01 | 1995-04-13 | Merrell Pharmaceuticals Inc. | INHIBITORS OF β-AMYLOID PROTEIN PRODUCTION |
EP0659418A1 (en) * | 1993-12-21 | 1995-06-28 | Eli Lilly And Company | 2-Phenyl-3-azoylbenzothiophene for treating Alzheimer's disease |
WO1996020725A2 (en) * | 1995-01-06 | 1996-07-11 | Sibia Neurosciences, Inc. | Peptide, peptide analog and amino acid analog protease inhibitors |
WO1996022966A1 (en) * | 1995-01-23 | 1996-08-01 | Biogen, Inc. | Cell adhesion inhibitors |
WO1997030072A1 (en) * | 1996-02-20 | 1997-08-21 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
Non-Patent Citations (1)
Title |
---|
See also references of WO9639194A1 * |
Also Published As
Publication number | Publication date |
---|---|
JPH11506923A (en) | 1999-06-22 |
CA2221684A1 (en) | 1996-12-12 |
EP0831920A1 (en) | 1998-04-01 |
WO1996039194A1 (en) | 1996-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG20993A (en) | Cleasing compositions | |
EG20989A (en) | Cleasing compositions | |
EP0831920A4 (en) | Novel cathepsin and methods and compositions for inhibition thereof | |
GB9613043D0 (en) | Improved compositions | |
NZ313189A (en) | Sunscreen compositions | |
HUP9900925A3 (en) | Sunscreen compositions | |
GB9614911D0 (en) | Sunscreen compositions | |
PL328877A1 (en) | Method of inhibiting cathepsin k | |
GB9500577D0 (en) | Compositions | |
ZA9510052B (en) | Sunscreen compositions | |
EP0733547A3 (en) | Ablator compositions | |
GB9508791D0 (en) | Compositions of matter | |
GB9504996D0 (en) | Compositions | |
GB9516371D0 (en) | Compositions | |
ZA961514B (en) | Novel compositions | |
GB9515805D0 (en) | Compositions | |
GB9510563D0 (en) | Well inhibition | |
GB9508785D0 (en) | Novel compositions | |
GB9604856D0 (en) | Compositions | |
HUP9601550A2 (en) | Particulale compositions | |
GB9510222D0 (en) | Compositions of matter | |
GB9510719D0 (en) | Novel compositions | |
GB9519109D0 (en) | Compositions | |
GB9517113D0 (en) | Novel compositions | |
SG64924A1 (en) | Inhibiting photodecompostion of 3-substituted-2- oxindoles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19971204 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 48/00 A, 7C 12Q 1/68 B, 7C 07H 21/02 B, 7C 07H 21/04 B, 7C 07K 5/06 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030131 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20021101 |